News InFlectis BioScience – PR IFB-088 Phase 1 SAD-15 05 2019 EN Home > InFlectis BioScience announces favorable results for IFB-088 Phase 1 Single Ascending Dose clinical trial > InFlectis BioScience – PR IFB-088 Phase 1 SAD-15 05 2019 EN 16 May 2019